MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
MHC 限制性磷酸肽抗原：针对高危黑色素瘤患者的临床前验证和首次人体临床试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2019-000262
Victor H Engelhard #, Rebecca C Obeng #, Kara L Cummings #, Gina R Petroni #, Angela L Ambakhutwala #, Kimberly A Chianese-Bullock #, Kelly T Smith, Amanda Lulu, Nikole Varhegyi, Mark E Smolkin, Paisley Myers, Keira E Mahoney, Jeffrey Shabanowitz, Nico Buettner, Emily H Hall, Kathleen Haden, Mark Co
